Sees low-single-digit Cash NOI growth for the triple-net portfolio, ignoring the impact of acquisitions and dispositions.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SBRA:
- Sabra Health Care reports Q3 adjusted FFO 38c, consensus 38c
- SBRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Sabra Health Care price target lowered to $20 from $21 at Wells Fargo
- Sabra Health Care price target raised to $22 from $21 at BofA
- Sabra Health Care initiated with a Neutral at Cantor Fitzgerald